You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ofatumumab

Showing 51 - 75 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukaemia Trial in Worldwide (Ofatumumab, Physicians' Choice)

Completed
Has Results
  • Leukaemia
  • Ofatumumab
  • Physicians' Choice
  • Graz, Austria
  • +79 more
Oct 9, 2018

Cancer Trial in United States (ofatumumab, bendamustine)

Completed
  • Cancer
  • Birmingham, Alabama
  • +4 more
Feb 27, 2018

Arthritis, Rheumatoid Trial in Worldwide (ofatumumab)

Terminated
Has Results
  • Arthritis, Rheumatoid
  • ofatumumab
  • Los Angeles, California
  • +9 more
Nov 27, 2017

Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular Trial in Aichi, Tokyo (ofatumumab)

Completed
  • Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular
  • ofatumumab
  • Aichi, Japan
  • +2 more
Nov 13, 2017

Follicular Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma Trial in Boston (ofatumumab)

Completed
Has Results
  • Follicular Lymphoma
  • +2 more
  • ofatumumab
  • Boston, Massachusetts
  • +2 more
Sep 18, 2017

DLBCL Trial in United States (Bendamustine, Ofatumumab)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Fort Myers, Florida
  • +10 more
Oct 19, 2017

Pemphigus Trial in Los Angeles, Ann Arbor (Ofatumumab, Acetaminophen/paracetamol, Antihistamine (cetirizine or equivalent))

Terminated
Has Results
  • Pemphigus
  • Ofatumumab
  • +3 more
  • Los Angeles, California
  • +1 more
May 12, 2017

Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma Trial in Belgium, France (Ofatumumab)

Completed
  • Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma
  • Ofatumumab
  • Antwerpen, Belgium
  • +83 more
Mar 6, 2018

Arthritis, Rheumatoid Trial in Worldwide (ofatumumab, Placebo)

Terminated
Has Results
  • Arthritis, Rheumatoid
  • ofatumumab
  • Placebo
  • Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • +44 more
Nov 2, 2017

Chronic Lymphocytic Leukemia Trial in United States (Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Denver, Colorado
  • +5 more
May 3, 2017

Arthritis, Rheumatoid Trial in Worldwide (, ofatumumab)

Completed
  • Arthritis, Rheumatoid
  • placebo
  • ofatumumab
  • Anniston, Alabama
  • +16 more
Jun 23, 2017

Chronic Lymphocytic Leukemia (CLL) Trial (Dinaciclib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Feb 17, 2017

Chronic Lymphocytic Leukemia Trial in Italy (Pentostatin, Cyclophosphamide, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Monza, MB, Italy
  • +11 more
Dec 27, 2016

Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic Trial in Worldwide (Ofatumumab, Bendamustine)

Completed
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Leukaemia, Lymphocytic, Chronic
  • Tuscon, Arizona
  • +32 more
Nov 22, 2016

Chronic Lymphatic Leukemia Trial in Germany (Ofatumumab)

Completed
  • Chronic Lymphatic Leukemia
  • Ofatumumab
  • Heidelberg, Baden-Württemberg, Germany
  • +10 more
Sep 16, 2016

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Ofatumumab
  • Thousand Oaks, California
  • +12 more
Aug 10, 2016

Waldenström Macroglobulinemia Trial in Buffalo, New York (biological, drug, other)

Terminated
Has Results
  • Waldenström Macroglobulinemia
  • ofatumumab
  • +2 more
  • Buffalo, New York
  • +1 more
May 3, 2016

Hodgkin Disease Trial in Spain (Ofatumumab)

Completed
  • Hodgkin Disease
  • Ofatumumab
  • Badalona, Barcelona, Spain
  • +13 more
Feb 23, 2016

Relapsed NLPHL Trial in Cologne (Ofatumumab)

Completed
  • Relapsed NLPHL
  • Ofatumumab
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Oct 30, 2015

Chronic Lymphocytic Leukemia Trial in Charleston, Greenville (Ofatumumab, Lenalidomide)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Charleston, South Carolina
  • +1 more
Nov 2, 2015

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone Trial (Ofatumumab)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Ofatumumab
  • (no location specified)
Oct 8, 2015

Lymphoma, Large-Cell, Diffuse Trial in London (Ofatumumab)

Completed
Has Results
  • Lymphoma, Large-Cell, Diffuse
  • Ofatumumab
  • London, United Kingdom
    GSK Investigational Site
Jul 2, 2015

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocyctic Leukemia Trial in Columbus (PCI-32765,

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    The Ohio State University
May 28, 2015

Lymphoma, Follicular Trial in Buffalo (Ofatumumab, Cyclophosphamide, Doxorubicin)

Completed
Has Results
  • Lymphoma, Follicular
  • Ofatumumab
  • +4 more
  • Buffalo, New York
    GSK Investigational Site
Jun 26, 2014

Non-Hodgkin Lymphomas Trial in Chicago, Niles, Park Ridge (Ofatumumab)

Terminated
Has Results
  • Non-Hodgkin Lymphomas
  • Ofatumumab
  • Chicago, Illinois
  • +2 more
Jul 2, 2014